{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T01:46:57Z","timestamp":1649036817620},"reference-count":26,"publisher":"Japanese Society of Internal Medicine","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2019,4,15]]},"DOI":"10.2169\/internalmedicine.1214-18","type":"journal-article","created":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T22:32:49Z","timestamp":1547073169000},"page":"1103-1110","source":"Crossref","is-referenced-by-count":2,"title":["Huge Hepatocellular Carcinoma Treated with Radical Hepatectomy after Drug-eluting Bead Transarterial Chemoembolization"],"prefix":"10.2169","volume":"58","author":[{"given":"Masashi","family":"Fujita","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Fukushima Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Okai","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Fukushima Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Fukushima Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumichi","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Fukushima Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Fukushima Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Hepato-Biliary-Pancreatic and Transplant Surgery, Fukushima Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Kenjo","sequence":"additional","affiliation":[{"name":"Department of Hepato-Biliary-Pancreatic and Transplant Surgery, Fukushima Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Marubashi","sequence":"additional","affiliation":[{"name":"Department of Hepato-Biliary-Pancreatic and Transplant Surgery, Fukushima Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Fukushima Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromasa","family":"Ohira","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Fukushima Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Matsui O, Miyayama S, Sanada J, et al. Interventional oncology: new options for interstitial treatments and intravascular approaches: superselective TACE using iodized oil for HCC: rationale, technique and outcome. J Hepatobiliary Pancreat Sci 17: 407-409, 2010.","DOI":"10.1007\/s00534-009-0234-z"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Lammer J, Malagari K, Vogl T, et al. Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol 33: 41-52, 2010.","DOI":"10.1007\/s00270-009-9711-7"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Song MJ, Chun HJ, Song DS, et al. Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma. J Hepatol 57: 1244-1250, 2012.","DOI":"10.1016\/j.jhep.2012.07.017"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Huang K, Zhou Q, Wang R, Cheng D, Ma Y. Doxorubicin-eluting bead versus conventional transarterial chemoembolization for the treatment of HCC: a meta-analysis. J Gastroenterol Hepatol 29: 920-925, 2014.","DOI":"10.1111\/jgh.12439"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kudo M, Ueshima K, Kubo S, et al. Response evaluation criteria in cancer of the liver (RECICL) (2015 Revised version). Hepatol Res 46: 3-9, 2016.","DOI":"10.1111\/hepr.12542"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41: 1313-1321, 2005.","DOI":"10.1002\/hep.20701"},{"key":"7","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","volume":"116","author":"CA Matteoni","year":"1999","unstructured":"7. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116: 1413-1419, 1999.","journal-title":"Gastroenterology","ISSN":"http:\/\/id.crossref.org\/issn\/0016-5085","issn-type":"print"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kokudo N, Hasegawa K, Akahane M, et al. Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma 2013: The Japan Society of Hepatology 2013 update (3rd JSH-HCC Guidelines). Hepatol Res 45: 123-127, 2015.","DOI":"10.1111\/hepr.12464"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Jin YJ, Lee JW, Choi YJ, et al. Surgery versus transarterial chemoembolization for solitary large hepatocellular carcinoma of BCLC stage A. J Gastrointest Surg 18: 555-561, 2014.","DOI":"10.1007\/s11605-013-2440-x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Zhu SL, Zhong JH, Ke Y, Ma L, You XM, Li LQ. Efficacy of hepatic resection vs transarterial chemoembolization for solitary huge hepatocellular carcinoma. World J Gastroenterol 21: 9630-9637, 2015.","DOI":"10.3748\/wjg.v21.i32.9630"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Yasuda S, Nomi T, Hokuto D, et al. Huge hepatocellular carcinoma with multiple intrahepatic metastases: an aggressive multimodal treatment. Int J Surg Case Rep 16: 44-47, 2015.","DOI":"10.1016\/j.ijscr.2015.09.016"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Huang YH, Wu JC, Chen SC, et al. Survival benefit of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma larger than 10 cm in diameter. Aliment Pharmacol Ther 23: 129-135, 2006.","DOI":"10.1111\/j.1365-2036.2006.02704.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Song MJ, Park CH, Kim JD, et al. Drug-eluting bead loaded with doxorubicin versus conventional Lipiodol-based transarterial chemoembolization in the treatment of hepatocellular carcinoma: a case-control study of Asian patients. Eur J Gastroenterol Hepatol 23: 521-527, 2011.","DOI":"10.1097\/MEG.0b013e328346d505"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Reis SP, Sutphin PD, Singal AG, et al. Tumor enhancement and heterogeneity are associated with treatment response to drug-eluting bead chemoembolization for hepatocellular carcinoma. J Comput Assist Tomogr 41: 289-293, 2017.","DOI":"10.1097\/RCT.0000000000000509"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Vesselle G, Quirier-Leleu C, Velasco S, et al. Predictive factors for complete response of chemoembolization with drug-eluting beads (DEB-TACE) for hepatocellular carcinoma. Eur Radiol 26: 1640-1648, 2016.","DOI":"10.1007\/s00330-015-3982-y"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. van Malenstein H, Maleux G, Vandecaveye V, et al. A randomized phase II study of drug-eluting beads versus transarterial chemoembolization for unresectable hepatocellular carcinoma. Oncol Res Treat 34: 368-376, 2011.","DOI":"10.1159\/000329602"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Klompenhouwer EG, Dresen RC, Verslype C, et al. Safety and efficacy of transarterial radioembolisation in patients with intermediate or advanced stage hepatocellular carcinoma refractory to chemoembolisation. Cardiovasc Intervent Radiol 40: 1882-1890, 2017.","DOI":"10.1007\/s00270-017-1739-5"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Brown KT. Fatal pulmonary complications after arterial embolization with 40-120- micro m tris-acryl gelatin microspheres. J Vasc Interv Radiol 15: 197-200, 2004.","DOI":"10.1097\/01.RVI.0000109400.52762.1F"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Spina JC, Ulla M, Yeyati EL, et al. MDCT \ufb01ndings after hepatic chemoembolization with DC-beads: what the radiologist needs to know. Abdom Imaging 38: 778-784, 2013.","DOI":"10.1007\/s00261-012-9963-6"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Padia SA, Shivaram G, Bastawrous S, et al. Safety and efficacy of drug-eluting bead chemoembolization for hepatocellular carcinoma: comparison of small-versus medium-size particles. J Vasc Interv Radiol 24: 301-306, 2013.","DOI":"10.1016\/j.jvir.2012.11.023"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Hsieh PM, Hung KC, Chen YS. Tumor lysis syndrome after transarterial chemoembolization of hepatocellular carcinoma: Case reports and literature review. World J Gastroenterol 15: 4726-4728, 2009.","DOI":"10.3748\/wjg.15.4726"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Cario MS, Bishop M. Tumor lysis syndrome: new therapeutic strategies and classification. Br J Haematol 127: 3-11, 2004.","DOI":"10.1111\/j.1365-2141.2004.05094.x"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Tosi P, Barosi G, Lazzaro C, et al. Consensus conference on the management of tumor lysis syndrome. Haematologica 93: 1877-1885, 2008.","DOI":"10.3324\/haematol.13290"},{"key":"24","unstructured":"24. Ikeda A, Yasuhara Y, Hirata D, et al. A case of resected hepatocellular carcinoma after drug-eluting bead transarterial chemoembolization. Nihon Shokakibyo Gakkai Zasshi (J Jpn Soc Gastroenterol) 113: 983-992, 2016 (in Japanese)."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Kurniawan J, Sulaiman AS, Matondang SB, Lalisang TJ, Krisnuhoni E, Zulkifly S. Complete remission after sequential therapy of drug eluting beads transarterial chemoembolization and liver resection in large solitary nodule hepatocellular carcinoma. Case Reports in Hepatology 2017.","DOI":"10.1155\/2017\/3682614"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Kudo M, Arizumi T, Ueshima K, Sakurai T, Kitano M, Nishida N. Subclassification of BCLC B stage hepatocellular carcinoma and treatment strategies: proposal of modified bolondi's subclassification (Kinki criteria). Dig Dis 33: 751-758, 2015.","DOI":"10.1159\/000439290"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/8\/58_1214-18\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,13]],"date-time":"2019-11-13T23:23:05Z","timestamp":1573687385000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/8\/58_1214-18\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,15]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.1214-18","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,15]]}}}